Company Active LTD

Company profile

Spatialcortex Technology Limited

SpatialCortex

SpatialCortex Technology and MOVA - MOVA is a revolutionary bio-mechanical monitoring system that enables quantitative assessment of manual handling injury risks in the work place. MOVA combines, SpatialCortex technology body worn, wireless sensors and proprietary software suite, to fully derive injury risk parameters in a quantitative and objective manner

CRN
12073913
Founded
2019
Age
7

Overview

Legal name
SPATIALCORTEX TECHNOLOGY LIMITED
Region
South West England
Registered address
20 BROOMFIELD
CHIPPENHAM
UNITED KINGDOM
SN15 1DZ
Insolvency history
No

Latest accounts

Financial period: 1 Jul 2024 to 30 Jun 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
6

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

25 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

11 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

27 Jun
2019

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2023
Funded years
2023, 2024
Age at first award
4 years

Projects

2024 Collaborative R&D Lead participant

Manual-handling injury prevention technology with AI enabled automatic risk detection, classification and intervention identification functionalities

1 Apr 2024 to 31 Mar 2025

Awarded
£51,334
Total cost £73,334

Musculoskeletal Disorders(MSDs) or Manual-handling injuries accounts for roughly a 1-in-3 workplace injuries in the UK and worldwide. MSDs impact businesses on financial, productivity, compliance and legal fronts. For staff, MSDs can lead to long-term health impact and reduced productivity and Quality-of-Life(QoL). MSDs also adds pressure to the healthcar...

2023 Investment Accelerator Lead participant

A wearable, AI enabled, workplace Musculoskeletal Disorder (MSD) reduction technology with risk-assessment, risk-prevention, and ergonomic-training functionalities

1 Dec 2023 to 30 Nov 2024

Awarded
£50,000
Total cost £50,000

Musculoskeletal Disorders(MSDs) or Manual-handling injuries accounts for roughly 1-in-3 workplace injuries in the UK and worldwide. MSDs impact businesses on financial, productivity, compliance and legal fronts. For staff, MSDs can lead to long-term health impact and reduced productivity and Quality-of-Life(QoL). MSDs also adds pressure to the healthcare ...

Product types

Collaborative R&D Investment Accelerator